Worldwide is the Full-Service CRO of Choice for Your Colon Cancer Study

Colon cancer, or cancer of the large intestine, has a high frequency of occurrence and is commonly treated by surgical resection, which proves particularly successful in earlier stages of the disease. The increasing complexity around cancer detection and treatment calls for individualized approaches to treatment, and clinical research requires multidisciplinary teams. Researchers have identified a need for new study strategies based on molecular biomarkers.

In the highly complex and competitive landscape of cancer research, you need a CRO partner like Worldwide Clinical Trials to give you a strategy for trial success. Our oncology experience has included Phase I-IV and non-interventional studies in solid tumors, hematological malignancies, and supportive care. We are a full-service provider, offering everything from pre-trial feasibility studies to study design and patient recruitment, investigational monitoring, and post-trial analysis. In addition, we offer real-world evidence options for teams ready to take their program to the next step.

With investigator sites in 60+ countries and a detailed understanding of regional regulatory considerations and standards of care, Worldwide can help you find the clinicians and patient populations that give you the data you need within your timeline